• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与肺炎球菌壁磷壁酸的新型抗原发生反应的保护性单克隆抗体。

A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.

作者信息

McDaniel L S, Waltman W D, Gray B, Briles D E

机构信息

Department of Microbiology, University of Alabama, Birmingham 35294.

出版信息

Microb Pathog. 1987 Oct;3(4):249-60. doi: 10.1016/0882-4010(87)90058-1.

DOI:10.1016/0882-4010(87)90058-1
PMID:2462151
Abstract

D3114/63 is a hybridoma cell line producing a monoclonal antibody that appears to recognize a common antigenic determinant associated with the teichoic acids of Streptococcus pneumoniae. This hybridoma was produced in a fusion of splenic lymphocytes from an X-linked immunodeficient (xid) male (CBA/NxBALB/c)F1 mouse hyperimmunized with a heat-killed type 6A strain EF-3114. Treatment of EF-3114 with periodate, but not with protease, destroyed its ability to bind D3114/63. The specificity of D3114/63 for teichoic acids was suggested by the ability of both C-polysaccharide and F-antigen to inhibit its binding to EF-3114. Inhibition studies indicated that D3114/63 does not bind the PC determinant of teichoic acids. As in the case with anti-PC antibodies, the presence of an intact pneumococcal capsule significantly reduced the binding of D3114/63 to viable pneumococci. By means of a colony immunoblot procedure, it was determined that D3114/63 bound to all 97 pneumococcal strains tested including representatives of 24 different serotypes. Both D3114/63 and anti-PC antibodies were able to detect pneumococcal antigen in spinal fluids of 3 out of 4 patients with pneumococcal meningitis. D3114/63 protected mice from fatal infection with type 3 strain WU2 pneumococci but not from type 5 strain DBL5 or type 6A strain EF-3114.

摘要

D3114/63是一种杂交瘤细胞系,可产生一种单克隆抗体,该抗体似乎能识别与肺炎链球菌磷壁酸相关的共同抗原决定簇。这种杂交瘤是由一只经热灭活的6A 型菌株EF - 3114超免疫的X连锁免疫缺陷(xid)雄性(CBA/N×BALB/c)F1小鼠的脾淋巴细胞融合产生的。用高碘酸盐而非蛋白酶处理EF - 3114,会破坏其与D3114/63结合的能力。C多糖和F抗原均能抑制D3114/63与EF - 3114的结合,这表明D3114/63对磷壁酸具有特异性。抑制研究表明,D3114/63不结合磷壁酸的PC决定簇。与抗PC抗体的情况一样,完整的肺炎球菌荚膜的存在会显著降低D3114/63与活肺炎球菌的结合。通过菌落免疫印迹法确定,D3114/63与所测试的全部97株肺炎球菌菌株结合,包括24种不同血清型的代表菌株。D3114/63和抗PC抗体均能在4例肺炎球菌性脑膜炎患者中的3例患者的脑脊液中检测到肺炎球菌抗原。D3114/63可保护小鼠免受3型菌株WU2肺炎球菌的致命感染,但不能保护其免受5型菌株DBL5或6A型菌株EF - 3114的感染。

相似文献

1
A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.一种与肺炎球菌壁磷壁酸的新型抗原发生反应的保护性单克隆抗体。
Microb Pathog. 1987 Oct;3(4):249-60. doi: 10.1016/0882-4010(87)90058-1.
2
Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.用于诊断肺炎球菌性脑膜炎的交叉反应性单克隆抗体。
J Clin Microbiol. 1988 Sep;26(9):1635-40. doi: 10.1128/jcm.26.9.1635-1640.1988.
3
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.针对蛋白酶敏感的肺炎球菌抗原的单克隆抗体可保护小鼠免受肺炎链球菌的致命感染。
J Exp Med. 1984 Aug 1;160(2):386-97. doi: 10.1084/jem.160.2.386.
4
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.C反应蛋白及抗肺炎球菌细胞壁和荚膜抗原单克隆抗体的抗肺炎球菌作用
Infect Immun. 1989 May;57(5):1457-64. doi: 10.1128/iai.57.5.1457-1464.1989.
5
Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.针对肺炎球菌荚膜多糖6B型的单克隆抗体的亲和力、效价和交叉反应性。
Infect Immun. 2001 Jan;69(1):336-44. doi: 10.1128/IAI.69.1.336-344.2001.
6
Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.抗磷酸胆碱抗体对小鼠感染肺炎链球菌的保护作用。
Infect Immun. 1982 Apr;36(1):184-8. doi: 10.1128/iai.36.1.184-188.1982.
7
Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.衰老过程中的抗体保护:独特型库及抗体与细菌抗原结合活性的影响
Exp Mol Pathol. 1995 Apr;62(2):99-108. doi: 10.1006/exmp.1995.1011.
8
Periodate oxidation of R36A pneumococci greatly enhances production of hybridomas secreting anti-protein antibodies.R36A肺炎球菌的高碘酸盐氧化极大地提高了分泌抗蛋白抗体的杂交瘤的产量。
Microb Pathog. 1998 Feb;24(2):111-6. doi: 10.1006/mpat.1997.0175.
9
Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.肺炎球菌9V型结合物单克隆抗体的制备、结合特性及保护性免疫
Microbiol Immunol. 1996;40(11):857-65. doi: 10.1111/j.1348-0421.1996.tb01151.x.
10
Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.肺炎链球菌PspA上诱导保护作用的表位在氨基酸残基192至260之间的定位。
Microb Pathog. 1994 Nov;17(5):323-37. doi: 10.1006/mpat.1994.1078.

引用本文的文献

1
The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.改良表面杀伤试验可区分对 PspA 的保护性和非保护性抗体。
mSphere. 2019 Dec 11;4(6):e00589-19. doi: 10.1128/mSphere.00589-19.
2
Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity.多重抗原呈递系统(MAPS)诱导全面的 B 细胞和 T 细胞免疫。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13564-9. doi: 10.1073/pnas.1307228110. Epub 2013 Jul 29.
3
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine.
肺炎球菌全细胞疫苗诱导产生广泛的抗体和 T 细胞反应。
Vaccine. 2012 Jun 19;30(29):4316-22. doi: 10.1016/j.vaccine.2012.01.034.
4
Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.针对粪肠球菌菌株12030的调理素抗体是针对脂磷壁酸的。
Infect Immun. 2006 Oct;74(10):5703-12. doi: 10.1128/IAI.00570-06.
5
Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.实验性人类肺炎球菌定植期间血清免疫球蛋白G对候选疫苗抗原的反应。
Infect Immun. 2003 Oct;71(10):5724-32. doi: 10.1128/IAI.71.10.5724-5732.2003.
6
Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.对肺炎链球菌的获得性而非先天性免疫反应会因CD40L的中和作用而受损。
Infect Immun. 2000 Feb;68(2):511-7. doi: 10.1128/IAI.68.2.511-517.2000.
7
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).肺炎球菌多样性:关于新疫苗策略的考量,重点关注肺炎球菌表面蛋白A(PspA)
Clin Microbiol Rev. 1998 Oct;11(4):645-57. doi: 10.1128/CMR.11.4.645.
8
Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.用肺炎链球菌表面蛋白A(PspA)进行口服免疫可引发针对肺炎链球菌感染的保护性体液免疫。
Infect Immun. 1997 Feb;65(2):640-4. doi: 10.1128/iai.65.2.640-644.1997.
9
Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.用于诊断肺炎球菌性脑膜炎的交叉反应性单克隆抗体。
J Clin Microbiol. 1988 Sep;26(9):1635-40. doi: 10.1128/jcm.26.9.1635-1640.1988.
10
Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.肺炎链球菌荚膜多糖的免疫原性和免疫化学
Antonie Van Leeuwenhoek. 1990 Jun;58(1):1-47. doi: 10.1007/BF02388078.